News & Press
Cumulus Neuroscience and Muse by Interaxon Bring Validated At-Home Sleep EEG to CNS Clinical Trials
www.prnewswire.com7/6/2026·07/06/26🌐 Global
Summary
Cumulus Neuroscience and Muse by Interaxon integrated Muse’s at-home sleep EEG wearable into the NeuLogiq multi-modal platform, enabling trial-grade sleep staging (88–96% agreement with polysomnography) alongside cognition, wake EEG, mood and speech measures for CNS clinical trials. The collaboration debuted at the Alzheimer’s Association International Conference 2026.
Why it matters
Validated at-home sleep EEG monitoring for CNS clinical trials could reduce the cost and patient burden of trial participation, an important practical enabler for CNS drug development broadly, not just neurotech devices.
#EEG#Sleep Tech#Clinical Trial#AI/ML
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in